生物活性 | |||
---|---|---|---|
靶点 |
|
||
描述 | Tubastatin A exhibits significant selectivity towards all 11 HDAC isoforms, maintaining over 1000-fold selectivity against all isoforms except HDAC8, for which it demonstrates approximately 57-fold selectivity. In assays assessing homocysteic acid (HCA)-induced neurodegeneration, Tubastatin A demonstrates dose-dependent protection against HCA-induced neuronal cell death, with significant protection observed at 5 μM and near complete protection at 10 μM[1]. Tubastatin A at a concentration of 100 ng/mL enhances the suppressive effect of Foxp3+ T-regulatory cells (Tregs) on T cell proliferation in vitro[2]. In CC12 cells, Tubastatin A treatment results in impaired myotube formation when alpha-tubulin undergoes early hyperacetylation during the myogenic process; however, myotube elongation ensues when alpha-tubulin is hyperacetylated in mature myotubes[3]. Tubastatin A treatment enhances cell elasticity, as demonstrated by atomic force microscopy (AFM) tests, without causing significant alterations to the actin microfilament or microtubule networks in mouse ovarian cancer cell lines, MOSE-E and MOSE-L[4]. |
细胞研究 | |||||
---|---|---|---|---|---|
细胞系 | 浓度 | 检测类型 | 检测时间 | 活动说明 | 数据源 |
134/04 | 7.5 µM | Function assay | impairs myotube formation | 22174839 | |
293T | ~2 μg/ml | Function assay | induces PTEN expression and membrane translocation | 26279303 | |
293T | ~2 μg/ml | Function assay | induces PTEN acetylation at K163 | 26279303 |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
2.69mL 0.54mL 0.27mL |
13.45mL 2.69mL 1.34mL |
26.89mL 5.38mL 2.69mL |
参考文献 |
---|